Published in Medical Devices and Surgical Technology Week, January 1st, 2006
This data included blood test results as well as histological examinations of various organs. All results were within safe limits. Doses equivalent to 50X the expected human dose were used in the test.
Dr. Anil Diwan, president of NanoViricides, Inc., stated that these positive findings give added confidence that the upcoming efficacy studies will show our drug system to be...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week